Obesity Research Study
The purpose of this study is to evaluate the effectiveness and safety of giving canagliflozin together with phentermine compared with placebo in the treatment of non-diabetic overweight subjects.
This study will last for approximately 28 weeks with a total of 7 office visits and 3 phone calls.
You will be compensated for time and travel.
You may qualify if the following apply to you: